Cargando…
Translation of MT-ATP6 pathogenic variants reveals distinct regulatory consequences from the co-translational quality control of mitochondrial protein synthesis
Pathogenic variants that disrupt human mitochondrial protein synthesis are associated with a clinically heterogeneous group of diseases. Despite an impairment in oxidative phosphorylation being a common phenotype, the underlying molecular pathogenesis is more complex than simply a bioenergetic defic...
Autores principales: | Ng, Kah Ying, Richter, Uwe, Jackson, Christopher B, Seneca, Sara, Battersby, Brendan J |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9029222/ https://www.ncbi.nlm.nih.gov/pubmed/34718584 http://dx.doi.org/10.1093/hmg/ddab314 |
Ejemplares similares
-
mtIF3 is locally translated in axons and regulates mitochondrial translation for axonal growth
por: Lee, Soyeon, et al.
Publicado: (2022) -
Clinical Heterogeneity in MT-ATP6 Pathogenic Variants: Same Genotype—Different Onset
por: Capiau, Sara, et al.
Publicado: (2022) -
Mitochondrial translational defect extends lifespan in C. elegans by activating UPR(mt)
por: Guo, Miaomiao, et al.
Publicado: (2023) -
Pathogenic variants in MT‐ATP6: A United Kingdom–based mitochondrial disease cohort study
por: Ng, Yi Shiau, et al.
Publicado: (2019) -
Regulation of mitochondrial translation of the ATP8/ATP6 mRNA by Smt1p
por: Rak, Malgorzata, et al.
Publicado: (2016)